A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Subtype-selective Electroporation of Cortical Interneurons

8.4K views

⸱

DOI:

10.3791/51518

⸱

August 18th, 2014

 , 

In This Article

Summary

This procedure shows how to target interneurons in the developing mouse forebrain by means of in utero electroporation. This technique was particularly efficient to achieve selective gene expression in interneuron subtypes destined to the superficial layers of the cortex.

Abstract

The study of central nervous system (CNS) maturation relies on genetic targeting of neuronal populations. However, the task of restricting the expression of genes of interest to specific neuronal subtypes has proven remarkably challenging due to the relative scarcity of specific promoter elements. GABAergic interneurons constitute a neuronal population with extensive genetic and morphological diversity. Indeed, more than 11 different subtypes of GABAergic interneurons have been characterized in the mouse cortex1. Here we present an adapted protocol for selective targeting of GABAergic populations. We achieved subtype selective targeting of GABAergic interneurons by using the enhancer element of the homeobox transcription factors Dlx5 and Dlx6, homologues of the Drosophila distal-less (Dll) gene2,3, to drive the expression of specific genes through in utero electroporation.

Introduction

The bulk of cortical GABAergic interneurons originate from two transient embryonic structures named the medial and caudal ganglionic eminences (MGE and CGE respectively)4. Parvalbumin and somatostatin expressing interneurons originate in the MGE whereas Calretinin (Cr), Vasointestinal peptide (VIP) and Reelin (Re) expressing interneurons originate from the CGE. These interneuron subtypes can be distinguished by their birthdates. MGE derived subtypes are born between embryonic day 9.5 (e9.5) and e16.55,6. In contrast, CGE derived interneurons are born from e12.5 through e18.5 with their production peaking at e15.56. The genetic targetin....

Access restricted. Please log in or start a trial to view this content.

Protocol

All animals were treated in accordance with the regulations and guidelines of the Institutional Animal Care and Use Committee of the NYU School of Medicine.

Mouse Strains
Swiss Webster female mice provided by TACONIC were used for these experiments. In order to specifically target superficial layer interneurons, e15.5 embryos were used.

Note: The plasmid used in this work (Dlx5/6.eGFP plasmid 3 µg/µl) was generated using standard cloning techniques. The eGFP cDNA was cloned into a Dlx5/6-Pmin-polyA plasmid. This plasmid is available upon request (demarn02@nyumc.org....

Access restricted. Please log in or start a trial to view this content.

Results

We adapted the in utero electroporation technique to achieve cell type specific targeting of maturing neurons. To drive the expression of eGFP in CGE-derived interneurons, we used the Dlx5/6 enhancer element and restricted our injections to e15.5, the stage when the majority of CGE-derived interneurons are generated. We carried out the analysis at P8 and P15 11(Figures 1 and 2). We confirmed the ventral origin of electroporated neurons by co electroporating a.......

Access restricted. Please log in or start a trial to view this content.

Discussion

Limitations of the Technique

While this technique allows for cell autonomous analysis of cell processes, it is not suitable for population analysis. The electroporations are very sparse with less than a thousand cells electroporated per brain. As a consequence, the technique cannot be used to assess behavioral consequences arising from the genetic manipulation of CGE-derived interneurons.

While electroporations carried out at e13.5-e14.5 target MGE-derived subtypes,.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have nothing to disclose.

Acknowledgements

We are grateful to Lihong Yin for technical assistance. NVD is a recipient of a NARSAD Young Investigator Award and is also supported by grants from NIH (5 K99 MH095825-02). Research in the Fishell lab is supported by the National Institute of Health, National Institute of Mental Health (5 R01 MH095147-02, 5 R01 MH071679-09), National Institute of Neurological Disorders and Stroke (5 R01 NS081297-02, 1 P01 NS074972-01A1) and the Simons Foundation.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
Electroporator  with pedalProtech InternationalCUY21
5 mm paddle electrodes Protech InternationalCUY650P5
Heating pad Kent ScientificDCT-15
Sutter Instruments P30 Puller Sutter Instruments3282322
Fluovac Anesthesia SystemsHarvard Apparatus726425
Delicate Operating Scissors 4.75" Straight Sharp/SharpRobozRS-6702
5-0 Silk Black Braid 18" C-1 Box 36 RobozSUT-1073-21
Micro Clip Applying Forceps 5.5"RobozRS-5410
2 Clamp scissorsRobozRC-4894
Holding forceps Fine Science Tools11031-15
Glass capillary tubing FHC27-30-0Borosil 1.0 mm OD x 0.75 mm ID
Fast GreenSigma-AldrichF7258 
Sterile PBSLife Technologies20012-027

References

  1. Fishell, G., Rudy, B. Mechanisms of inhibition within the telencephalon: "where the wild things are". Annual review of neuroscience. 34, 535-567 (2011).
  2. Stenman, J., Toresson, H., Campbell, K.

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

In Utero ElectroporationGABAergic InterneuronsDlx5 Dlx6 EnhancerSubtype Selective TargetingDNA InjectionElectroporation ProtocolEmbryonic Chain RemovalGFP Expression VisualizationCell Autonomous Analysis